Talk:Assessment of the health impacts of H1N1 vaccination/Group E
Pandemrix should not be used because of narcolepsy risk
Anna, Sallamari
Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
Resolution: Not accepted mainly because risks are small and benefits high. (A stable resolution, when found, should be updated to the main page.) |
Argumentation:
⇤J1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) ←J2 The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)
⇤E6 : The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit. --Sallamari Tynkkynen 10:57, 1 April 2011 (EEST) [3]
⇤E4 : The side effects of Pandemrix have been accentuated, although the benefits are much more significant. --Sallamari Tynkkynen 10:50, 1 April 2011 (EEST) [4] ⇤E5 : Nursing staff in hospitals should be vaccinated; it is their responsibility as medical professionals. --Sallamari Tynkkynen 10:54, 1 April 2011 (EEST) [4]
|
See also
References
- ↑ 1.0 1.1 European Medicines Agency (EMA): Information page on Swine flu
- ↑ THL press release 25 Aug 2010
- ↑ 3.0 3.1 THL press release 9 Dec 2010
- ↑ 4.0 4.1 Helsingin Sanomat: Arkkiatri moittii sikainfluenssarokotteen vastustajia (in Finnish)